Skip to main content

Table 1 Demographic and clinical data

From: The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the “Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)” project

 

Schizophrenia (n = 2498)

Major depressive disorder (n = 1022)

p-value

Age (mean ± SD)

45.63 ± 15.60

58.65 ± 17.26

1.1 × 10–98

Sex (female, n, %)

1354 (54.2)

666 (65.2)

2.4 × 10–9

PRN psychotropic prescription ratio (n, %)

718 (28.7)

311 (30.4)

0.32

PRN antipsychotic prescription ratio (n, %)

443 (17.7)

101 (9.9)

*4.9 × 10–9

PRN anxiolytic and hypnotic prescription ratio (n, %)

465 (18.6)

237 (23.2)

*2.0 × 10–3

PRN antidepressant prescription ratio (n, %)

13 (0.5)

22 (2.2)

*9.4 × 10–6

PRN antiparkinsonian prescription ratio (n, %)

55 (2.2)

4 (0.4)

*1.5 × 10–4

  1. As the level of significance, p < 5.5 × 10–3, was within the 5% significance level, based on the Bonferroni correction, it was considered in the multiplicity of the tests
  2. PRN pro re nata, SD standard deviation
  3. *p < 0.05, after the Bonferroni correction